Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy

BACKGROUND: Delivery of therapeutic small interfering RNA (siRNA) via functionalized nanoparticles holds great promise for cancer therapy. However, developing a safe and efficient delivery carrier of siRNA is a challenging issue. METHODS: RGDfC peptide was used to modify the surface of selenium nano...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changbing, Xia, Yu, Huo, Shaochuan, Shou, Diwen, Mei, Qing, Tang, Wenjuan, Li, Yinghua, Liu, Hongsheng, Zhou, Yongjian, Zhu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723231/
https://www.ncbi.nlm.nih.gov/pubmed/33304100
http://dx.doi.org/10.2147/IJN.S270441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723231/
https://www.ncbi.nlm.nih.gov/pubmed/33304100
http://dx.doi.org/10.2147/IJN.S270441

Ejemplares similares